Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal morphine plus low-dose bupivacaine versus standard-dose bupivacaine for haemorrhoidectomy analgesia
2012-000110-11Phase 4Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind trial of morphine hydrochloride and bupivacaine in postoperative pain (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias. Primary endpoint: Analgesic effect measured by a visual analgesic scale. Started Mar 2012; status: active.
02
Drugs
morphine hydrochloridebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2012-000110-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000110-11.